Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis

Y Yang, L Yang, J Wu, J Hu, M Wan, J Bie, J Li, D Pan… - Clinical Nutrition, 2024 - Elsevier
Background Probiotic administration is a promising therapy for improving conditions in
NAFLD patients. This network meta-analysis aimed to compare and estimate the relative …

Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review …

Y Zhu, JK Tan, J Liu, JA Goon - Antioxidants, 2024 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and its progressive stage, non-alcoholic
steatohepatitis (NASH), are becoming one of the most common chronic liver diseases …

Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial

N Reshef, U Gophna, L Reshef, F Konikoff, G Gabay… - Nutrients, 2024 - mdpi.com
Several studies show that gut microbiotas in patients with nonalcoholic fatty liver disease
(NAFLD) differ from those in a healthy population, suggesting that this alteration plays a role …

Gut microbiota in MAFLD: therapeutic and diagnostic implications

W Alghamdi, M Mosli… - Therapeutic Advances in …, 2024 - journals.sagepub.com
Metabolic dysfunction-associated fatty liver disease (MAFLD), formerly known as
nonalcoholic fatty liver disease, is becoming a significant contributor to chronic liver disease …

[HTML][HTML] Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect

XX Qiu, SL Cheng, YH Liu, Y Li, R Zhang… - World Journal of …, 2024 - ncbi.nlm.nih.gov
The population of non-alcoholic fatty liver disease (NAFLD) patients along with relevant
advanced liver disease is projected to continue growing, because currently no medications …

Gut microbiota and metabolite interface-mediated hepatic inflammation

M Yang, K Massad, ET Kimchi… - …, 2024 - journals.lww.com
Immunologic and metabolic signals regulated by gut microbiota and relevant metabolites
mediate bidirectional interaction between the gut and liver. Gut microbiota dysbiosis, due to …

The influence of liver cirrhosis, additional probiotics, and alcohol consumption on hepatic fibrosis and the gut microbiota deserves attention

F Du, L Tao - The Journal of Nutrition, 2024 - jn.nutrition.org
We have read with interest the article published by Escouto GS et al [1]. At present,
nonalcoholic steatohepatitis (NASH) has gradually become a research hotpot in the field of …

Probióticos y prebióticos como potenciales modificadores del microbioma intestinal en el tratamiento de la enfermedad hepática esteatósica asociada a disfunción …

V Rao, G Bell - 2023 - titula.universidadeuropea.com
Introducción La enfermedad hepática esteatósica asociada a disfunción metabólica es una
condición causada por el acúmulo excesivo de triglicéridos a nivel hepático en ausencia de …

Reply to F Du and L Tao

C Buss, A Marette, GS Escouto… - The Journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Reply to F Du and L Tao Reply to F Du and L Tao J Nutr. 2024 Jun;154(6):1960. doi:
10.1016/j.tjnut.2024.04.002. Epub 2024 Apr 9. Authors Caroline Buss 1 , André Marette 2 …

Role of Plantaricin Produced by Lactiplantibacillus Plantarum in Alleviating Third-Generation Antibiotic Toxicity in a Zebrafish (Danio Rerio) Model

MN Subramanyam, DN Thanjavur, B Viswanath… - Available at SSRN … - papers.ssrn.com
Plantaricin, a bacteriocin, was synthesized and subjected to partial purification from
Lactiplantibacillus plantarum. The precipitation processes yielded plantaricin with the …